Voyager Therapeutics, Inc. announced the appointment of Todd Carter, Ph.D., as Chief Scientific Officer (CSO), and Trista Morrison as Senior Vice President of Corporate Affairs. Todd Carter, Ph.D., is an accomplished neuroscientist with more than 20 years of experience in the life science industry. Carter's work has been cited in over 20 key research publications on neurological indications including Alzheimer's disease, mental health disorders, and spinal muscular atrophy.

He most recently served as Voyager's Senior Vice President of Research, supporting the development of the company's TRACER™ platform, the identification of novel AAV capsids, and the execution of multiple successful industry partnerships. Prior to joining Voyager in 2016, Carter served as the Senior Science Advisor to the Office of the Director of the Broad Institute of MIT and Harvard, where he focused on advancing innovative science concepts toward the clinic. Prior to that, he held research positions at BrainCells Inc. and Ambit Biosciences Inc. He received a B.A. in genetics from Texas A&M University and a Ph.D. in genetics from Columbia University, and he completed his postdoctoral training at the Salk Institute for Biomedical Research.

Trista Morrison has more than 20 years of experience in healthcare public affairs, including strategic communications, investor relations and patient advocacy. Most recently she served as Chief Corporate Affairs Officer for rare disease company Saniona, where she built and led communications, investor relations, patient advocacy and government relations functions. Previously, Morrison served as Vice President of Communications and Patient Advocacy for Sobi in North America.

She has also held positions at PR with Purpose; Ironwood Pharmaceuticals, Inc.; BioWorld Today; and multiple public relations agencies. Morrison received a B.S. in biology and marketing from Tulane University. Carter and Morrison will report to Voyager CEO Al Sandrock, M.D., Ph.D., and will serve on Voyager's Senior Leadership Team.

Pfreundschuh's, Carter's and Morrison's appointments will each become effective on September 19.